NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available
here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package
read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read
here
See how UMR members are aiding in the fight against the coronavirus
here
A new episode of the
Amazing Things Podcast is now available! Check it out
here.
Harvard’s Wyss Institute collaborates with GBS Inc. on the Wyss’ eRapid-based COVID-19 diagnostic to help curb the pandemic
The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute’s eRapid technology with the company’s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.